Trial Profile
Efficacy and safety of pazopanib for recurrent or metastatic solitary fibrous tumor: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2018
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Solitary-fibrous-tumour
- Focus Adverse reactions; Therapeutic Use
- 19 Jul 2018 New trial record